In July 2002 the Directors were introduced to the Microgenix air purification system. This technology appears to be appropriate to the current environmental conditions. Following some detailed due diligence a subsequent negotiation and acquisition was completed, whereby Voicenet (Aust) Ltd acquired fifty percent of a new joint venture company - Microgenix Technologies Limited (UK) - with the inventor of Microgenix, Mr Philip Hall. The Microgenix system is considered to be leading edge in the extraction of airborne diseases, and Microgenix has established that it can extract up to 99.8 percent of viruses, such as Anthrax and Smallpox, among others.
In light of the present economic climate, war in the Middle East and global terrorism, Microgenix Technologies Limited (UK) will have a significant role in ensuring the safety of the general population and the Board is pleased to report that the technology is at a stage where commercialisation can commence. Microgenix Technologies Limited (UK) has successfully sold one license in Canada for US$1m and is presently negotiating a number of licences and manufacturing contracts worldwide. Microgenix Technologies Limited (UK) will provide Voicenet (Aust) Ltd the chance to rejuvenate itself, thus providing significant future opportunities for the shareholders.
